Clinical studies show that lower doses of GLP-1 agonists are highly effective at reducing hemoglobin A1c (which indicates the average blood sugar level over the past 2-3 months), improving insulin sensitivity, and directly addressing the metabolic dysregulation often associated with estrogen decline and perimenopausal weight gain, helping to stabilize energy levels and reduce fat-storage signaling
Patients taking multiple medications should discuss potential interactions, though GLP-1 receptor agonists have minimal hepatic metabolism interactions
When You May Need To Pay Cash And How To Reduce Costs If insurance won't cover wegovy or similar drugs, patients may face full cash prices
Before discussing any medication, our team focuses on understanding your health history, current weight, body composition, lifestyle, eating patterns, previous weight loss attempts, medications, lab markers, and risk factors